Priscilla Chan on Broadening Rare-Disease Research

A short argument for putting research tools in more hands, with context on spinal muscular atrophy.

PCPriscilla ChanIntervenant
Chaîne
No Priors: AI, Machine Learning, Tech, & Startups
Publié
7 juil. 2026
Vidéo
1:03
Lecture
1 min
Original
anglais
Ouvrir sur YouTube
En faisant défiler, la vidéo se réduit en bas à droite et continue. Les sous-titres suivent votre langue de lecture.
Langue de lectureDisponible en 2 langues
Cet article n’est pas encore disponible en français ; il s’affiche dans l’original en anglais.
RÉSUMÉ

En 30 secondes

Priscilla Chan argues that rare diseases may be overlooked by research strategies focused on large populations. She suggests broader access to tools could support more targeted research; SMA already has active research and approved treatments.

  1. 1A long tailCommon disease categories contain many distinct subtypes, alongside rare diseases.
  2. 2Broader accessChan argues for giving more researchers tools to pursue neglected questions.
  3. 3SMA contextSMA has active research and approved treatments.

À retenir

  1. Disease categories include many subtypes.
  2. Rare diseases can receive less attention in population-focused research.
  3. Chan favors broader access to research tools.
  4. SMA already has approved treatments.
TEXTE INTÉGRAL

Lire le texte remanié, chapitre par chapitre

Transcription seule
01

Researching the long tail

Priscilla Chan argues that disease categories contain many subtypes, and that rare conditions may receive less attention when research focuses on interventions affecting the largest numbers of people.

Priscilla Chan argues that disease categories contain many subtypes, and that rare conditions may receive less attention when research focuses on interventions affecting the largest numbers of people.

She proposes putting research tools in more people’s hands so that individuals and smaller groups can pursue conditions they care about. As an example, she mentions spinal muscular atrophy (SMA).

Chan suggests that studying a rare disease can also reveal broader biological mechanisms. This is an argument for widening research participation, not a guarantee that a particular tool or project will produce a treatment.

SMA is already the subject of active research and has approved treatments; it should not be understood from the clip’s headline as a disease nobody studies. For example, the FDA has approved gene therapy for specified SMA patients. [FDA announcement](https://www.fda.gov/news-events/press-announcements/fda-approves-gene-therapy-treatment-spinal-muscular-atrophy).

Sur la même chaîne

38:06EN
No Priors: AI, Machine Learning, Tech, & Startups· 29 oct. 2026Podcast · 3 voixServal’s Jake Stauch on coding agents for enterprise ITInvité : Jake Stauch · Anime : Sarah Guo, Elad GilStauch explains why Serval is challenging ServiceNow, how it approaches permissions and approvals, and why background agents remain difficult to deploy safely.IA en entrepriseAgents de codeWorkflow automation+2
39:23EN
No Priors: AI, Machine Learning, Tech, & Startups· 15 oct. 2026Podcast · 2 voixThe Defenders' Window: Greg Brockman on AI-Generated Knowledge, Drug Discovery, and the New Physics of CybersecurityAnime : Sarah Guo, Elad GilOpenAI's president explains why solving open math problems is a proof point for science, how proactive agents change product form, and why security spending must exceed software spending.SécuritéAI securitySécurité et gouvernance+3
1:09:44EN
No Priors: AI, Machine Learning, Tech, & Startups· 9 oct. 2026Podcast · 2 voix10,000 GB300s for Four Weeks: Reflection’s Open-Model LedgerAnime : Sarah Guo, Elad GilMisha Laskin tells No Priors how Reflection trained Beam, why reinforcement learning outspent pre-training, and why the West needs its own open weights.Open source et communautéOpen-weight modelsReinforcement Learning+3
35:39EN
No Priors: AI, Machine Learning, Tech, & Startups· 2 oct. 2026Podcast · 2 voixCompute Scaled a Millionfold. Bandwidth Only 40x. Fractile Wants to Fix That RatioAnime : Sarah Guo, Elad GilIn the summer of 2022, Walter Goodwin founded Fractile in London to build very fast inference chips for the world's largest models.Infrastructure et déploiementInferenceAI cost & performance+3
42:44EN
No Priors: AI, Machine Learning, Tech, & Startups· 24 sept. 2026Podcast · 2 voixThey Paid $7.7 Billion for a Broker — and Intend to Do One Deal a YearAnime : Sarah Guo, Elad GilSequence Holdings co-founder Michael Lee tells No Priors why owning a market leader, not selling it software, is how AI actually remakes an incumbent.Entreprise et stratégieIA en entrepriseAI Strategy+3
38:14EN
No Priors: AI, Machine Learning, Tech, & Startups· 18 sept. 2026Podcast · 2 voixDiffusion Will Win Inference: Stefano Ermon Bets Parallel Tokens Beat Custom SiliconAnime : Sarah Guo, Elad GilThe Stanford diffusion pioneer tells No Priors why a 50-person lab is training language models that generate many tokens at once — and why that maps to GPUs the way transformers once mapped to training.Modèles et entraînementInferenceAI cost & performance+3